IN VITRO DIAGNOSTIC METHOD FOR PATIENTS WITH SPLENIC MARGINAL ZONE LYMPHOMA

WIPO Patent Application WO/2011/154579

A4

The present invention describes an in vitro SMZL diagnostic method based on analysis of the expression of a series of genes located in a very specific deleted region of human chromosome 7. The deleted region in SMZL patients has been defined by means of high-resolution array CGH and is located at 7q22.1 between bases 99925039-101754718, preferably between 99925039-101348479, and more preferably between 100260234-100596921 and/or 101244026-101754718, which is the location for the following genes: CUX1, SH2B2, EPHB4, SLC12A9, TRIP6, SRRT, ACHE, UFSP1, TRIM56, SERPINE1, APIS1, VGF, TSC22D4, HRBL, LRCH4, MUC3, MUC12 and MUC17. The present invention further describes in vitro SMZL diagnostic kits that comprise at least one probe that recognizes the deleted region at 7q22.1 or hybridizes with at least one of the nucleotide sequences of the genes mentioned above.

JP2004205414	NUCLEIC ACID MICROARRAY, METHOD FOR MANUFACTURING THE SAME AND METHOD FOR USING THE SAME
JP4246459	How to purify oil-contaminated soil
WO/2010/025566	RNA MONOMERS CONTAINING O-ACETAL LEVULINYL ESTER GROUPS AND THEIR USE IN RNA MICROARRAYS

HERNANDEZ RIVAS JESUS MARIA (ES)
GARCIA HERNANDEZ JUAN LUIS (ES)
ROBLEDO MONTERO CRISTINA (ES)

PCT/ES2011/070406

February 23, 2012

June 07, 2011

Click for automatic bibliography generation  

FUNDACION DE INVESTIGACION DEL CANCER DE LA UNIVERSIDAD DE SALAMANCA FICUS (ES)
HERNANDEZ RIVAS JESUS MARIA (ES)
GARCIA HERNANDEZ JUAN LUIS (ES)
ROBLEDO MONTERO CRISTINA (ES)

C12Q1/68

ILLESCAS TABOADA, Manuel (13 5º Izda, Madrid, ES)

View/Download PDF      PDF Help

Previous Patent: HANGING LOCKET CONTAINING ELEMENTS FOR OPTICAL USE

Next Patent: NOVEL CXCR4 INHIBITORS AS ANTI-HIV AGENTS